What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Search narrowed by
Cefpodoxime New
PSUR-outcome
|
27/09/2024
Further information and amendments to the product information can be found on the EMA website.
Codeine/Ibuprofen New
PSUR-outcome
|
16/09/2024
Further information and amendments to the product information can be found on the EMA website.
Dydrogesterone/Estradiol New
PSUR-outcome
|
13/09/2024
Further information and amendments to the product information can be found on the EMA website.
salicylic acid (topical use) New
PSUR-outcome
|
13/09/2024
Further information and amendments to the product information can be found on the EMA website.
Methotrexate New
PSUR-outcome
|
05/09/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Havrix and associated names New
Referral
|
02/09/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Methylprednisolone (systemic formulations) New
PSUR-outcome
|
02/09/2024
Further information and amendments to the product information can be found on the EMA website.
Hydroxycarbamide New
PSUR-outcome
|
30/08/2024
Further information and amendments to the product information can be found on the EMA website.
Atorvastatin New
PSUR-outcome
|
19/08/2024
Further information and amendments to the product information can be found on the EMA website.
Bumetanide New
PRAC signal recommendation
|
14/08/2024
Risko for toxic epidermal necrolysis and Stevens-Johnson syndrome. Further information and amendments to the product information can be found on the EMA website.